Effect of the consumption of yacon flour and energy-restricted diet on glycation markers, and association between these markers and factors linked to obesity in adults with excess body weight: A randomized, double-blind, placebo-controlled clinical trial

Blüher, 2019, Obesity: global epidemiology and pathogenesis, Nat Rev Endocrinol, 15, 288, 10.1038/s41574-019-0176-8 World Health Organization. Obesity and overweight 2020. Available at: https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight. Accessed July 6, 2021. Chooi, 2019, The epidemiology of obesity, Metabolism, 92, 6, 10.1016/j.metabol.2018.09.005 Matafome, 2017, Methylglyoxal in metabolic disorders: facts, myths, and promises, Med Res Rev, 37, 368, 10.1002/med.21410 Uribarri, 2005, Diet-derived advanced glycation end products are major contributors to the body's AGE pool and induce inflammation in healthy subjects, Ann N Y Acad Sci, 1043, 461, 10.1196/annals.1333.052 Ramasamy, 2005, Advanced glycation end products and RAGE: a common thread in aging, diabetes, neurodegeneration, and inflammation, Glycobiology, 15, 16R, 10.1093/glycob/cwi053 Song, 2014, RAGE regulates the metabolic and inflammatory response to high-fat feeding in mice, Diabetes, 63, 1948, 10.2337/db13-1636 Gaens, 2014, Nε-(carboxymethyl)lysine-receptor for advanced glycation end product axis is a key modulator of obesity-induced dysregulation of adipokine expression and insulin resistance, Arterioscler Thromb Vasc Biol, 34, 1199, 10.1161/ATVBAHA.113.302281 Ueno, 2010, Receptor for advanced glycation end-products (RAGE) regulation of adiposity and adiponectin is associated with atherogenesis in apoE-deficient mouse, Atherosclerosis, 211, 431, 10.1016/j.atherosclerosis.2010.04.006 Uribarri, 2010, Advanced glycation end products in foods and a practical guide to their reduction in the diet, J Am Diet Assoc, 110, 10.1016/j.jada.2010.03.018 Goldin, 2006, Advanced glycation end products: sparking the development of diabetic vascular injury, Circulation, 114, 597, 10.1161/CIRCULATIONAHA.106.621854 Miyata, 1997, Implication of an increased oxidative stress in the formation of advanced glycation end products in patients with end-stage renal failure, Kidney Int, 51, 1170, 10.1038/ki.1997.160 Tanaka, 2000, The receptor for advanced glycation end products is induced by the blycation products themselves and tumor necrosis factor-α through nuclear factor-κB, and by 17β-estradiol through Sp-1 in human vascular endothelial cells, J Biol Chem, 275, 25781, 10.1074/jbc.M001235200 Neeper, 1992, Cloning and expression of a cell surface receptor for advanced glycosylation end products of proteins, J Biol Chem, 267, 14998, 10.1016/S0021-9258(18)42138-2 Yonekura, 2003, Novel splice variants of the receptor for advanced glycation end-products expressed in human vascular endothelial cells and pericytes, and their putative roles in diabetes-induced vascular injury, Biochem J, 370, 1097, 10.1042/bj20021371 Hudson, 2008, Identification, classification, and expression of RAGE gene splice variants, FASEB J, 22, 1572, 10.1096/fj.07-9909com Bray, 2018, The science of obesity management: an Endocrine Society scientific statement, Endocr Rev, 39, 79, 10.1210/er.2017-00253 Lachman, 2003, Yacon [Smallanthus sonchifolia (Poepp. et Endl.) H. Robinson] chemical composition and use—a review, Plant Soil Environ, 49, 283, 10.17221/4126-PSE Silva, 2018, Optimization of enzymatic treatment to produce yacon juice clarified by microfiltration with high levels of chlorogenic acid and fructooligosaccharides, J Food Process Preserv, 42, e13641, 10.1111/jfpp.13641 Caetano, 2016, Yacon (Smallanthus sonchifolius) as a food supplement: health-promoting benefits of fructooligosaccharides, Nutrients, 8, 436, 10.3390/nu8070436 Campos, 2012, Prebiotic effects of yacon (Smallanthus sonchifolius Poepp. & Endl), a source of fructooligosaccharides and phenolic compounds with antioxidant activity, Food Chem, 135, 1592, 10.1016/j.foodchem.2012.05.088 Apolinário, 2014, Inulin-type fructans: a review on different aspects of biochemical and pharmaceutical technology, Carbohydr Polym, 101, 368, 10.1016/j.carbpol.2013.09.081 Machado, 2019, Consumption of yacon flour improves body composition and intestinal function in overweight adults: a randomized, double-blind, placebo-controlled clinical trial, Clin Nutr ESPEN, 29, 22, 10.1016/j.clnesp.2018.12.082 Salas-Salvadó, 2007, Consenso SEEDO 2007 para la evaluación del sobrepeso y la obesidad y el establecimiento de criterios de intervención terapéutica, Med Clin (Barc), 128, 184, 10.1016/S0025-7753(07)72531-9 Stunkard, 1985, The three-factor eating questionnaire to measure dietary restraint, disinhibition and hunger, J Psychosom Res, 29, 71, 10.1016/0022-3999(85)90010-8 World Medical Association. World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA 2013;310:2191–4. 2016 2005 Genta, 2009, Yacon syrup: beneficial effects on obesity and insulin resistance in humans, Clin Nutr, 28, 182, 10.1016/j.clnu.2009.01.013 Satoh, 2014, Yacon supplementation reduces serum free fatty acids and tumor necrosis factor alpha concentrations in patients with type 2 diabetes, Diabetol Int, 5, 165, 10.1007/s13340-013-0150-y Scheid, 2014, Freeze-dried powdered yacon: effects of FOS on serum glucose, lipids and intestinal transit in the elderly, Eur J Nutr, 53, 1457, 10.1007/s00394-013-0648-x Williams, 2018, 2018 ESC/ESH guidelines for the management of arterial hypertension, Eur Heart J, 39, 3021, 10.1093/eurheartj/ehy339 Friedewald, 1972, Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge, Clin Chem, 18, 499, 10.1093/clinchem/18.6.499 Matthews, 1985, Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man, Diabetologia, 28, 412, 10.1007/BF00280883 Ashraf, 2015, Recent advances in detection of AGEs: immunochemical, bioanalytical and biochemical approaches, IUBMB Life, 67, 897, 10.1002/iub.1450 Bradford, 1976, A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding, Anal Biochem, 72, 248, 10.1016/0003-2697(76)90527-3 Johnson, 1986, The alkaline reducing activity of glycated serum proteins and its relevance to diabetes mellitus, Clin Chem, 32, 368, 10.1093/clinchem/32.2.368 Palma-Duran, 2018, Serum levels of advanced glycation end-products (AGEs) and the decoy soluble receptor for AGEs (sRAGE) can identify non-alcoholic fatty liver disease in age-, sex- and BMI-matched normo-glycemic adults, Metabolism, 83, 120, 10.1016/j.metabol.2018.01.023 Meyer, 1983 Morettin, 1987 Magalhães, 2001 Tavares, 2020, Can advanced glycation end-products and their receptors be affected by weight loss? a systematic review, Obes Rev, 21, e13000, 10.1111/obr.13000 Rodríguez, 2015, Reduction of serum advanced glycation end-products with a low calorie mediterranean diet, Nutr Hosp, 31, 2511 Deo, 2017, Effects of weight loss on advanced glycation end products in subjects with and without diabetes: a preliminary report, Int J Environ Res Public Health, 14, 1553, 10.3390/ijerph14121553 Gugliucci, 2009, Short-term low calorie diet intervention reduces serum advanced glycation end products in healthy overweight or obese adults, Ann Nutr Metab, 54, 197, 10.1159/000217817 Norata, 2009, Circulating soluble receptor for advanced glycation end products is inversely associated with body mass index and waist/hip ratio in the general population, Nutr Metab Cardiovasc Dis, 19, 129, 10.1016/j.numecd.2008.03.004 Maillard-Lefebvre, 2009, Soluble receptor for advanced glycation end products: a new biomarker in diagnosis and prognosis of chronic inflammatory diseases, Rheumatology, 48, 1190, 10.1093/rheumatology/kep199 Herold, 2007, Receptor for advanced glycation end products (RAGE) in a dash to the rescue: inflammatory signals gone awry in the primal response to stress, J Leukoc Biol, 82, 204, 10.1189/jlb.1206751 Yamagishi, 2006, Positive association between serum levels of advanced glycation end products and the soluble form of receptor for advanced glycation end products in nondiabetic subjects, Metabolism, 55, 1227, 10.1016/j.metabol.2006.05.007 Aubert, 2014, Association of peripheral neuropathy with circulating advanced glycation end products, soluble receptor for advanced glycation end products and other risk factors in patients with type 2 diabetes, Diabetes Metab Res Rev, 30, 679, 10.1002/dmrr.2529 Ribeiro, 2019, Effect of reducing dietary advanced glycation end products on obesity-associated complications: a systematic review, Nutr Rev, 77, 725, 10.1093/nutrit/nuz034 Nakamura, 2007, Serum levels of sRAGE, the soluble form of receptor for advanced glycation end products, are associated with inflammatory markers in patients with type 2 diabetes, Mol Med, 13, 185, 10.2119/2006-00090.Nakamura Bopp, 2008, sRAGE is elevated in septic patients and associated with patients outcome, J Surg Res, 147, 79, 10.1016/j.jss.2007.07.014 Pullerits, 2006, Soluble receptor for advanced glycation end products triggers a proinflammatory cytokine cascade via β2 integrin Mac-1, Arthritis Rheum, 54, 3898, 10.1002/art.22217 Wang, 2010, sRAGE induces human monocyte survival and differentiation, J Immunol, 185, 1822, 10.4049/jimmunol.0903398 Hagen, 2015, Soluble receptor for advanced glycation end products as a potential biomarker to predict weight loss and improvement of insulin sensitivity by a very low calorie diet of obese human subjects, Cytokine, 73, 265, 10.1016/j.cyto.2015.02.022 Miranda, 2018, Endogenous secretory RAGE increases with improvements in body composition and is associated with markers of adipocyte health, Nutr Metab Cardiovasc Dis, 28, 1155, 10.1016/j.numecd.2018.07.009 Parikh, 2014, Randomized pilot trial of bariatric surgery versus intensive medical weight management on diabetes remission in type 2 diabetic patients who do NOT meet NIH criteria for surgery and the role of soluble RAGE as a novel biomarker of success, Ann Surg, 260, 617, 10.1097/SLA.0000000000000919 Lorenzi, 2014, Anti-sRAGE autoimmunity in obesity: downturn after bariatric surgery is independent of previous diabetic status, Diabetes Metab, 40, 356, 10.1016/j.diabet.2014.04.008 Brix, 2012, The soluble form of the receptor of advanced glycation endproducts increases after bariatric surgery in morbid obesity, Int J Obes, 36, 1412, 10.1038/ijo.2012.107